178 related articles for article (PubMed ID: 31936154)
1. Structure Modeling of the Norepinephrine Transporter.
Góral I; Łątka K; Bajda M
Biomolecules; 2020 Jan; 10(1):. PubMed ID: 31936154
[TBL] [Abstract][Full Text] [Related]
2. Comparative modeling of the human monoamine transporters: similarities in substrate binding.
Koldsø H; Christiansen AB; Sinning S; Schiøtt B
ACS Chem Neurosci; 2013 Feb; 4(2):295-309. PubMed ID: 23421681
[TBL] [Abstract][Full Text] [Related]
3. Guidelines for Homology Modeling of Dopamine, Norepinephrine, and Serotonin Transporters.
Haddad Y; Heger Z; Adam V
ACS Chem Neurosci; 2016 Nov; 7(11):1607-1613. PubMed ID: 27596073
[TBL] [Abstract][Full Text] [Related]
4. Mutations of tyrosine 467 in the human norepinephrine transporter attenuate HIV-1 Tat-induced inhibition of dopamine transport while retaining physiological function.
Strauss MJ; Porter KD; Quizon PM; Davis SE; Lin S; Yuan Y; Martinez-Muniz GA; Sun WL; Zhan CG; Zhu J
PLoS One; 2022; 17(9):e0275182. PubMed ID: 36170295
[TBL] [Abstract][Full Text] [Related]
5. Clobenpropit, a histamine H
Mena-Avila E; Márquez-Gómez R; Aquino-Miranda G; Nieto-Alamilla G; Arias-Montaño JA
Pharmacol Rep; 2018 Feb; 70(1):146-155. PubMed ID: 29414147
[TBL] [Abstract][Full Text] [Related]
6. LeuT-desipramine structure reveals how antidepressants block neurotransmitter reuptake.
Zhou Z; Zhen J; Karpowich NK; Goetz RM; Law CJ; Reith ME; Wang DN
Science; 2007 Sep; 317(5843):1390-3. PubMed ID: 17690258
[TBL] [Abstract][Full Text] [Related]
7. Emerging structure-function relationships defining monoamine NSS transporter substrate and ligand affinity.
Wang CI; Lewis RJ
Biochem Pharmacol; 2010 Apr; 79(8):1083-91. PubMed ID: 19954741
[TBL] [Abstract][Full Text] [Related]
8. Putative drug binding conformations of monoamine transporters.
Ravna AW; Sylte I; Kristiansen K; Dahl SG
Bioorg Med Chem; 2006 Feb; 14(3):666-75. PubMed ID: 16216517
[TBL] [Abstract][Full Text] [Related]
9. Exploring the Inhibitory Mechanism of Approved Selective Norepinephrine Reuptake Inhibitors and Reboxetine Enantiomers by Molecular Dynamics Study.
Zheng G; Xue W; Wang P; Yang F; Li B; Li X; Li Y; Yao X; Zhu F
Sci Rep; 2016 May; 6():26883. PubMed ID: 27230580
[TBL] [Abstract][Full Text] [Related]
10. Binding Mode of Human Norepinephrine Transporter Interacting with HIV-1 Tat.
Adeniran C; Yuan Y; Davis SE; Lin C; Xu J; Zhu J; Zhan CG
ACS Chem Neurosci; 2021 May; 12(9):1519-1527. PubMed ID: 33886267
[TBL] [Abstract][Full Text] [Related]
11. Binding site residues control inhibitor selectivity in the human norepinephrine transporter but not in the human dopamine transporter.
Andersen J; Ringsted KB; Bang-Andersen B; Strømgaard K; Kristensen AS
Sci Rep; 2015 Oct; 5():15650. PubMed ID: 26503701
[TBL] [Abstract][Full Text] [Related]
12. Further structural exploration of trisubstituted asymmetric pyran derivatives (2S,4R,5R)-2-benzhydryl-5-benzylamino-tetrahydropyran-4-ol and their corresponding disubstituted (3S,6S) pyran derivatives: a proposed pharmacophore model for high-affinity interaction with the dopamine, serotonin, and norepinephrine transporters.
Zhang S; Fernandez F; Hazeldine S; Deschamps J; Zhen J; Reith ME; Dutta AK
J Med Chem; 2006 Jul; 49(14):4239-47. PubMed ID: 16821783
[TBL] [Abstract][Full Text] [Related]
13. Differential Internalization Rates and Postendocytic Sorting of the Norepinephrine and Dopamine Transporters Are Controlled by Structural Elements in the N Termini.
Vuorenpää A; Jørgensen TN; Newman AH; Madsen KL; Scheinin M; Gether U
J Biol Chem; 2016 Mar; 291(11):5634-5651. PubMed ID: 26786096
[TBL] [Abstract][Full Text] [Related]
14. Interaction of antidepressants with the serotonin and norepinephrine transporters: mutational studies of the S1 substrate binding pocket.
Sørensen L; Andersen J; Thomsen M; Hansen SM; Zhao X; Sandelin A; Strømgaard K; Kristensen AS
J Biol Chem; 2012 Dec; 287(52):43694-707. PubMed ID: 23086945
[TBL] [Abstract][Full Text] [Related]
15. Structural basis of norepinephrine recognition and transport inhibition in neurotransmitter transporters.
Pidathala S; Mallela AK; Joseph D; Penmatsa A
Nat Commun; 2021 Apr; 12(1):2199. PubMed ID: 33850134
[TBL] [Abstract][Full Text] [Related]
16. Coordination of Na(+) by monoamine ligands in dopamine, norepinephrine, and serotonin transporters.
Xhaard H; Backström V; Denessiouk K; Johnson MS
J Chem Inf Model; 2008 Jul; 48(7):1423-37. PubMed ID: 18543980
[TBL] [Abstract][Full Text] [Related]
17. Focus on Human Monoamine Transporter Selectivity. New Human DAT and NET Models, Experimental Validation, and SERT Affinity Exploration.
Ortore G; Orlandini E; Betti L; Giannaccini G; Mazzoni MR; Camodeca C; Nencetti S
ACS Chem Neurosci; 2020 Oct; 11(20):3214-3232. PubMed ID: 32991141
[TBL] [Abstract][Full Text] [Related]
18. X-ray structures of Drosophila dopamine transporter in complex with nisoxetine and reboxetine.
Penmatsa A; Wang KH; Gouaux E
Nat Struct Mol Biol; 2015 Jun; 22(6):506-508. PubMed ID: 25961798
[TBL] [Abstract][Full Text] [Related]
19. Development of potent dopamine-norepinephrine uptake inhibitors (DNRIs) based on a (2S,4R,5R)-2-benzhydryl-5-((4-methoxybenzyl)amino)tetrahydro-2H-pyran-4-ol molecular template.
Santra S; Sharma H; Vedachalam S; Antonio T; Reith M; Dutta A
Bioorg Med Chem; 2015 Feb; 23(4):821-8. PubMed ID: 25593099
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological and behavioral characterization of D-473, an orally active triple reuptake inhibitor targeting dopamine, serotonin and norepinephrine transporters.
Dutta AK; Santra S; Sharma H; Voshavar C; Xu L; Mabrouk O; Antonio T; Reith ME
PLoS One; 2014; 9(11):e113420. PubMed ID: 25427177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
